The Drug Utilization Review (DUR) Board serves in an advisory capacity to the Department and makes recommendations regarding issues of drug utilization, provider education interventions, and application of standards. The Board meets once quarterly. The Board consists of nine members appointed by the Executive Director; four physicians, four pharmacists licensed and actively practicing in Colorado, and one non-voting pharmaceutical industry representative.

The DUR Board also determines the prior authorization criteria for drugs with special prescribing guidelines and the prior authorization criteria for non-preferred drugs, those that don't make the Preferred Drug List (PDL).

Presenting testimony

Interested parties that would like to present testimony to the DUR Board must sign up at least 24 hours in advance by contacting Kim Eggert at 303-866-3176 or kimberly.eggert@state.co.us

DUR Next Meeting

Tuesday  November 10, 2009

6:30pm - 9:30pm

PLEASE NOTE THAT THE LOCATION WILL BE:

225 E. 16th Avenue, 1st Floor Conference Room

Denver, CO  80203

DUR Meeting Minutes